|Bid||177.01 x 800|
|Ask||200.00 x 1400|
|Day's range||176.18 - 181.78|
|52-week range||104.28 - 199.83|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||29.55|
|Earnings date||21 Oct 2020 - 26 Oct 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||198.53|
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries and government and public health organisations, today announced that it is launching Accellacare a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralised trials. The site network includes previously acquired PMG Research in the US and MeDiNova Research in EMEA.
ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference
ICON's (NASDAQ:ICLR) stock is up by a considerable 12% over the past three months. Given the company's impressive...